APA

Yau T., Hsu C., Kim T., Choo S., Kang Y., Hou M., Numata K., Yeo W., Chopra A., Ikeda M., Kuromatsu R., Moriguchi M., Chao Y., Zhao H., Anderson J., Dela Cruz C. & Kudo M. (2019). Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]. : Journal of hepatology.

Chicago

Yau Thomas, Hsu Chiun, Kim Tae-You, Choo Su-Pin, Kang Yoon-Koo, Hou Ming-Mo, Numata Kazushi, Yeo Winnie, Chopra Akhil, Ikeda Masafumi, Kuromatsu Ryoko, Moriguchi Michihisa, Chao Yee, Zhao Huanyu, Anderson Jeffrey, Dela Cruz Christine and Kudo Masatoshi. 2019. Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]. : Journal of hepatology.

Harvard

Yau T., Hsu C., Kim T., Choo S., Kang Y., Hou M., Numata K., Yeo W., Chopra A., Ikeda M., Kuromatsu R., Moriguchi M., Chao Y., Zhao H., Anderson J., Dela Cruz C. and Kudo M. (2019). Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]. : Journal of hepatology.

MLA

Yau Thomas, Hsu Chiun, Kim Tae-You, Choo Su-Pin, Kang Yoon-Koo, Hou Ming-Mo, Numata Kazushi, Yeo Winnie, Chopra Akhil, Ikeda Masafumi, Kuromatsu Ryoko, Moriguchi Michihisa, Chao Yee, Zhao Huanyu, Anderson Jeffrey, Dela Cruz Christine and Kudo Masatoshi. Corrigendum to "Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis" [J Hepatol 71 (2019) 543-552]. : Journal of hepatology. 2019.